Description Melanotan 2 (MT-2) Research Peptide (10 mg) Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of endogenous -melanocyte-stimulating hormone (-MSH), developed at the University of Arizona as a structurally minimized, conformationally constrained derivative designed to improve metabolic stability and receptor selectivity relative to the native hormone and its linear analogue Melanotan 1
in this case discontinue Trulicity/dulaglutide and seek medical advice Acute kidney injury, monitor the renal function in patients with renal impairment and report severe gastrointestinal reactions Severe gastrointestinal disease, as usage may sometimes be associated with severe gastrointestinal reactions
Retatrutide (LY3437943), developed by Eli Lilly, is a once-weekly injectable GIP/GLP-1/glucagon triple receptor agonist
Frequently Asked Questions Why does Mounjaro cause lightheadedness
Benefits patients commonly report Supports the body's natural fat metabolism pathways Supports steady energy and reduces the drag of low B12 Often paired with weight management programs to complement diet and movement Supports liver function and healthy fat processing Quick weekly format that is easy to integrate into your routine A note on whole body wellness Healthier liver function, better metabolic balance, and improved energy show up in small visible ways, including clearer skin, more consistent sleep, and steadier mood across the week